These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2815104)

  • 1. Regulation of carcinogens in terms of life shortening.
    Albert RE; Shukla R
    Toxicol Ind Health; 1989 Oct; 5(5):791-5. PubMed ID: 2815104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 'secondary mechanism' in the regulation of carcinogens; a chronology.
    Scheuplein RJ
    Cancer Lett; 1995 Jun; 93(1):103-12. PubMed ID: 7600537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
    Gaylor DW; Aylward LL
    Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays.
    Paini A; Scholz G; Marin-Kuan M; Schilter B; O'Brien J; van Bladeren PJ; Rietjens IM
    Mutagenesis; 2011 Sep; 26(5):605-18. PubMed ID: 21642616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extrapolation to humans of the results of carcinogenicity tests].
    Turusov VS; Parfenov IuD
    Vopr Onkol; 1984; 30(6):3-16. PubMed ID: 6377689
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prospects of the development of research into regulating chemical carcinogens in the environment].
    Kurliandskiĭ BA; Shabad LM
    Vopr Onkol; 1979; 25(8):57-61. PubMed ID: 483703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Various suggestions on the unification of methods for experimental substantiation of maximum permissible concentration of chemical carcinogens].
    Litvinov NN; Titova TA
    Gig Sanit; 1977 Oct; (10):69-73. PubMed ID: 598727
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride).
    Roberts SM; Jordan KE; Warren DA; Britt JK; James RC
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):44-55. PubMed ID: 11846635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending the threshold of regulation concept: de minimis limits for carcinogens and mutagens.
    Fiori JM; Meyerhoff RD
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):209-16. PubMed ID: 12052005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogen risk assessment in the U.S. Environmental Protection Agency.
    Albert RE
    Crit Rev Toxicol; 1994; 24(1):75-85. PubMed ID: 8172652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating "safe" levels, a hazardous undertaking.
    Mantel N; Schneiderman MA
    Cancer Res; 1975 Jun; 35(6):1379-86. PubMed ID: 1131812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the relative potency of carcinogens: a critique of the HERP index].
    Boffetta P; Perera F
    Med Lav; 1989; 80(6):458-66. PubMed ID: 2698442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of environmental carcinogen risks in terms of life shortening.
    Albert RE; Altshuler B
    Environ Health Perspect; 1976 Feb; 13():91-4. PubMed ID: 1269512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment of peak exposure to genotoxic carcinogens: a pragmatic approach.
    Bos PM; Baars BJ; van Raaij MT
    Toxicol Lett; 2004 Jun; 151(1):43-50. PubMed ID: 15177639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems in prediction of toxicity and risk of effects of chemical substances on public health].
    Rumiantsev GI; Novikov SM
    Gig Sanit; 1997; (6):13-8. PubMed ID: 9483844
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment.
    Thomas RS; Clewell HJ; Allen BC; Wesselkamper SC; Wang NC; Lambert JC; Hess-Wilson JK; Zhao QJ; Andersen ME
    Toxicol Sci; 2011 Mar; 120(1):194-205. PubMed ID: 21097997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.